Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1302 | 2629 | 30.7 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
283 | 18382 | EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PLERIXAFOR | Author keyword | 140 | 72% | 4% | 111 |
2 | LARGE VOLUME LEUKAPHERESIS | Author keyword | 61 | 95% | 1% | 20 |
3 | STEM CELL MOBILIZATION | Author keyword | 49 | 41% | 4% | 93 |
4 | PERIPHERAL BLOOD STEM CELLS | Author keyword | 49 | 37% | 4% | 104 |
5 | POOR MOBILIZERS | Author keyword | 44 | 100% | 1% | 16 |
6 | LEUKAPHERESIS | Author keyword | 39 | 39% | 3% | 78 |
7 | MOBILIZATION | Author keyword | 31 | 15% | 7% | 191 |
8 | CD34 CELLS | Author keyword | 30 | 22% | 5% | 121 |
9 | PBPC MOBILIZATION | Author keyword | 27 | 78% | 1% | 18 |
10 | CD34 | Author keyword | 23 | 11% | 8% | 203 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PLERIXAFOR | 140 | 72% | 4% | 111 | Search PLERIXAFOR | Search PLERIXAFOR |
2 | LARGE VOLUME LEUKAPHERESIS | 61 | 95% | 1% | 20 | Search LARGE+VOLUME+LEUKAPHERESIS | Search LARGE+VOLUME+LEUKAPHERESIS |
3 | STEM CELL MOBILIZATION | 49 | 41% | 4% | 93 | Search STEM+CELL+MOBILIZATION | Search STEM+CELL+MOBILIZATION |
4 | PERIPHERAL BLOOD STEM CELLS | 49 | 37% | 4% | 104 | Search PERIPHERAL+BLOOD+STEM+CELLS | Search PERIPHERAL+BLOOD+STEM+CELLS |
5 | POOR MOBILIZERS | 44 | 100% | 1% | 16 | Search POOR+MOBILIZERS | Search POOR+MOBILIZERS |
6 | LEUKAPHERESIS | 39 | 39% | 3% | 78 | Search LEUKAPHERESIS | Search LEUKAPHERESIS |
7 | MOBILIZATION | 31 | 15% | 7% | 191 | Search MOBILIZATION | Search MOBILIZATION |
8 | CD34 CELLS | 30 | 22% | 5% | 121 | Search CD34+CELLS | Search CD34+CELLS |
9 | PBPC MOBILIZATION | 27 | 78% | 1% | 18 | Search PBPC+MOBILIZATION | Search PBPC+MOBILIZATION |
10 | CD34 | 23 | 11% | 8% | 203 | Search CD34 | Search CD34 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLUS G CSF | 139 | 74% | 4% | 104 |
2 | LARGE VOLUME LEUKAPHERESIS | 91 | 70% | 3% | 75 |
3 | BLOOD PROGENITOR CELLS | 82 | 32% | 8% | 215 |
4 | AUTOLOGOUS TRANSPLANTATION | 64 | 22% | 10% | 260 |
5 | G CSF | 61 | 15% | 14% | 360 |
6 | HIGH DOSE CHEMOTHERAPY | 54 | 11% | 17% | 454 |
7 | BLOOD STEM CELLS | 52 | 34% | 5% | 126 |
8 | PLATELET RECOVERY | 51 | 37% | 4% | 109 |
9 | COBE SPECTRA | 50 | 88% | 1% | 23 |
10 | NON LYMPHOBLASTIC LEUKEMIA | 47 | 62% | 2% | 48 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF HEMATOTHERAPY | 18 | 35% | 2% | 42 |
2 | JOURNAL OF CLINICAL APHERESIS | 12 | 13% | 3% | 90 |
3 | INTERNATIONAL JOURNAL OF CELL CLONING | 6 | 12% | 2% | 50 |
4 | JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH | 4 | 11% | 2% | 40 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations | 2014 | 15 | 160 | 68% |
The biology and clinical uses of blood stem cells | 1997 | 521 | 200 | 51% |
CD34: Structure, biology, and clinical utility | 1996 | 659 | 111 | 34% |
Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept | 2012 | 21 | 38 | 92% |
Therapeutic relevance of CD34(+) cell dose in blood cell transplantation for cancer therapy | 2000 | 191 | 103 | 50% |
Advances in stem cell mobilization | 2014 | 9 | 141 | 38% |
Improving stem cell mobilization strategies: future directions | 2009 | 98 | 130 | 56% |
Current status of stem cell mobilization | 2010 | 47 | 137 | 58% |
The evolving role of plerixafor in hematopoietic progenitor cell mobilization | 2013 | 6 | 77 | 77% |
Structural and functional features of the CD34 antigen: an update | 2001 | 79 | 75 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UTAH BLOOD MARROW TRANSPLANT PROGRAM | 6 | 80% | 0.2% | 4 |
2 | HPC TRANSPLANT PROGRAMME | 6 | 100% | 0.2% | 4 |
3 | HEMATOL ONCOLHEMATOPOIET STEM CELL TRANSPLAN | 4 | 75% | 0.1% | 3 |
4 | HEMATOL STEM CELL TRANSPLANTAT CLIN | 4 | 75% | 0.1% | 3 |
5 | ANALYT CLIN BIOCHEM | 3 | 100% | 0.1% | 3 |
6 | UNITE BIOCLIN PRELEVEMENT TRAITEMENT CELLULES S | 3 | 100% | 0.1% | 3 |
7 | CLIN HE IS UNIT | 3 | 50% | 0.2% | 4 |
8 | SERV BIOTHER IES | 3 | 50% | 0.2% | 4 |
9 | MED ONCOL BLOOD DIS | 3 | 60% | 0.1% | 3 |
10 | IMMUNOHEMATOL SECT | 3 | 32% | 0.3% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000185265 | HAPLOIDENTICAL//NORMAL DONORS//T CELL DEPLETION |
2 | 0.0000136065 | TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE |
3 | 0.0000117941 | BONE MARROW PURGING//MARROW PURGING//MAFOSFAMIDE |
4 | 0.0000111687 | EX VIVO EXPANSION//CYTOKINE MEDIATED EXPANSION//AFT024 |
5 | 0.0000076947 | G CSF//GM CSF//GRANULOCYTE COLONY STIMULATING FACTOR |
6 | 0.0000076936 | CORD BLOOD TRANSPLANTATION//UMBILICAL CORD BLOOD//CORD BLOOD |
7 | 0.0000065369 | PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM |
8 | 0.0000058810 | MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB |
9 | 0.0000052992 | FOLLICULAR LYMPHOMA//NON HODGKINS LYMPHOMA//AGGRESSIVE NON HODGKINS LYMPHOMA |
10 | 0.0000049808 | LYMPHOCYTE RECOVERY//IMMUNE RECONSTITUTION//BMT RECIPIENTS |